The nation of Zimbabwe has rejected a significant US health deal valued at 367 million US dollars (£272m) spanning five years due to Washington's insistence on sensitive information.
This move was revealed after a official document from December was leaked, which showed President Emmerson Mnangagwa felt the agreement was "skewed".
A government spokesman has since stated that the United States was demanding access to genetic material for research and commercial purposes but was unwilling to share the resulting advantages from any future treatments.
"We must now begin the challenging and unfortunate task of ending our health assistance in Zimbabwe," remarked US ambassador to Zimbabwe Pamela Tremont publicly.
Her embassy indicated the United States had furnished more than $1.9bn in health funding to Zimbabwe during the past two decades.
A doctors' association in Zimbabwe has appealed for further dialogue to reach a deal acceptable to both sides so the country's critical HIV treatment initiative can be sustained.
Broader Context
Zimbabwe's decision comes after a comparable case in neighbouring Kenya, where a court halted a similar health funding agreement following legal challenges were raised about the safety of Kenyans' health data.
Since returning to the presidency last year, US President Donald Trump has drastically cut foreign aid and closed the key foreign aid agency.
The agency had administered assistance for the American government, but Trump claimed its expenditure was "wasteful" and his administration was pursuing government-to-government agreements to boost transparency and accountability.
According to statements, 16 African countries have to date agreed to these new agreements, representing more than $18.3bn of fresh investment.
Specifics of the Rejected Deal
The funds for Zimbabwe was intended to funded "HIV/Aids treatment and prevention, tuberculosis, malaria, maternal and child health, and disease outbreak preparedness.
"We believe this collaboration could have provided extraordinary benefits for the people of Zimbabwe, particularly the 1.2 million men, women and children presently receiving HIV treatment through American-funded initiatives," Tremont commented.
However, government spokesperson Nick Mangwana said the arrangement was "unfair".
"Zimbabwe was being asked to share its biological resources and data for a long time, without any equivalent guarantee of access to any medical innovations – such as new medicines or tests – that could result from that shared data," Mangwana explained.
"In essence, our country would provide the raw materials for medical research without any assurance that the end products would be available to our population if a future disease outbreak arise."
Sovereignty and Global Health
He also pointed out that the US's withdrawal from the World Health Organization (WHO) and its pursuit of bilateral deals were disrupting structures previously established via the international organization.
Mangwana cited its Pandemic Benefit-Sharing scheme designed to deal with future global health emergencies.
"This mechanism is designed to guarantee that when a country contributes its information, the resulting advantages – including medicines and cures – are distributed fairly, not monopolised solely by those with the capability to create them."
The government's concerns regarding the US deal "must not be interpreted as hostility towards the US," he added.
"We welcome ongoing dialogue with our American counterparts on how future co-operation could be designed in a way that honours the sovereignty and dignity of both nations."
Health Experts Reaction
The Zimbabwe College of Public Health Physicians (ZCPHP) said it recognised the government's concerns, but suggested that talks must proceed since a large portion of the country's HIV programmes were funded by foreign aid.
"If technical issues exist, such as those relating to data governance or agreement terms, these can often be resolved through technical clarification and mutually agreed protections," it added.
The situation underscores the continuing tensions between receiving vital foreign assistance and protecting a country's data in an increasingly data-driven world.